Physician profile
William A Mcclelland
NPI 1174552707
$2,015.02
in general payments reported to CMS, 2019-2025
14 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.97 · 2020: $102 · 2021: $1,172 · 2022: $123 · 2024: $144 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,324.69 | 2021-2025 | Audion Et Dilation System |
| Genzyme Corporation | $169.86 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $121.77 | 2025 | Tezspire |
| Aerin Medical INC. | $118.54 | 2024 | |
| Inspire Medical Systems, INC. | $48.02 | 2025 | Inspire |
| Intersect Ent, INC. | $37.52 | 2019-2020 | |
| Alk-Abello, INC | $34.74 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $33.65 | 2025 | |
| Forte Bio-Pharma LLC | $26.68 | 2021 | |
| Integra Lifesciences Corporation | $25.29 | 2024 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Acclarent, INC | $23.19 | 2020 | |
| Greer Laboratories, INC. | $18.15 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $17.92 | 2020 | |
| Medtronic USA, INC. | $15.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mcclelland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.